article thumbnail

With little FDA oversight, melatonin supplements vary widely in actual dosage, study finds

STAT

One product was even three times more powerful than the label suggested. Researchers tested the melatonin concentration in more than two dozen gummy dietary supplements that recently launched and that were available at mainstream retailers like Amazon and Walmart. Nearly all of the products had more than 10% more melatonin than advertised.

Dosage 246
article thumbnail

Labelling of Dispensed Medicine

RX Note

Labelling Requirements A ll dispensed medicine should be labelled according to the requirement stated by the law. NOTE: It is advisable for labels to be printed. Consequently, a patient-centred label strategy is introduced to promote appropriate medication use and adherence. fever, cough or cold).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Labetalol batch recalled due to wrong dosage labelling

The Pharmacist

A batch of Labetalol 200mg tablets has been recalled as they are incorrectly labelled as 100mg tablets on the foil blister packaging. Pharmacists have been instructed to immediately stop […] The post Labetalol batch recalled due to wrong dosage labelling appeared first on The Pharmacist.

Dosage 98
article thumbnail

The Comprehensive Science and Art of Pharmaceutical Drug Naming

Drug Patent Watch

Pharmaceutical drug names are more than just a label - they're a carefully crafted code that conveys essential information about the medication. From the prefix that indicates the type of active ingredient to the suffix that signals the dosage form, every letter and symbol has a specific meaning.

article thumbnail

Off-label Use

RX Note

In fact, off-label drug uses can become widely entrenched in clinical practice and become predominant treatments for a given clinical condition. In a study published in JAMA Internal Medicine , off-label use lacking strong scientific evidence had a higher adverse drug event rate compared with on-label use.

article thumbnail

FDA Releases Draft Labeling Guidance for Biosimilar Products

Big Molecule Watch

Last week, FDA released a draft guidance, “ Labeling for Biosimilar and Interchangeable Biosimilar Products ” (“2023 Draft Guidance”) that—when finalized—will revise and replace its July 2018 final guidance, “ Labeling for Biosimilar Products.” The fictitious example provided in the 2023 Draft Guidance is “replicamab-cznm.”

article thumbnail

Alembic secures USFDA approval for Diltiazem Hydrochloride extended-release capsules

Express Pharma

The label provides a detailed indication. Diltiazem Hydrochloride Extended-Release Capsules USP in the 120 mg, 180 mg, and 240 mg dosages have an estimated market size of US$ 28.2 Diltiazem hydrochloride may be used alone or in combination with other antihypertensive medications, such as diuretics.

Dosage 105